
COMMISSION IMPLEMENTING REGULATION (EU) 2020/1643 of 5 November 2020 amending Implementing Regulation (EU) No 540/2011 as regards the approval periods of the active substances calcium phosphide, denathonium benzoate, haloxyfop-P, imidacloprid, pencycuron and zeta-cypermethrin (Text with EEA relevance) (revoked) 

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

Article 1 
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Article 2 
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
ANNEX

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
